Glenmark Pharmaceuticals Begins Marketing Two Drugs In US

Mumbai: Drug-maker Glenmark Pharmaceuticals has began marketing arthritis-related drug Nabumetone tablets and anxiety medicine Hydroxyzine Hydrochloride tablets in the US, after having got final regulatory clearance. The US Food and Drug Administration clearance for different strengths of generic Nabumetone tablets and Hydroxyzine Hydrochloride tablets was via its partnership with InvaGen Pharmaceuticals Inc (InvaGen). In December 2005, Glenmark and InvaGen had forayed into a collaboration pact for the joint development, filing and marketing of seven generic pharmaceutical products for the US. Glenmark said on March 13 that it will exclusively market and distribute Nabumetone and Hydroxyzine Hydrochloride tablets, while InvaGen will be responsible for its manufacture and supply.